BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38349517)

  • 21. Effects of sex steroids on women's health: implications for practitioners.
    Derman RJ
    Am J Med; 1995 Jan; 98(1A):137S-143S. PubMed ID: 7825634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From diagnosis to treatment of androgen-secreting ovarian tumors: a practical approach.
    Rojewska P; Meczekalski B; Bala G; Luisi S; Podfigurna A
    Gynecol Endocrinol; 2022 Jul; 38(7):537-542. PubMed ID: 35647677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperandrogenism in a postmenopausal woman: diagnostic and therapeutic challenges.
    Cheng V; Doshi KB; Falcone T; Faiman C
    Endocr Pract; 2011; 17(2):e21-5. PubMed ID: 21247854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
    Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
    Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal androgen-secreting ovarian tumors: challenging differential diagnosis in two cases.
    Arteaga E; Martinez A; Jaramilo J; Villaseca P; Cuello M; Valenzuela P; Gejman R; Blumel JE
    Climacteric; 2019 Aug; 22(4):324-328. PubMed ID: 30623686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leydig cell hyperplasia as a cause of virilization in a postmenopausal woman: A case report.
    Vatopoulou A; Gkrozou F; Birbas E; Kanavos T; Skentou C; Miliaras D
    Case Rep Womens Health; 2023 Sep; 39():e00537. PubMed ID: 37692362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism.
    Sarfati J; Bachelot A; Coussieu C; Meduri G; Touraine P;
    Eur J Endocrinol; 2011 Nov; 165(5):779-88. PubMed ID: 21896622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of patients with atypical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma.
    Dennedy MC; Smith D; O'Shea D; McKenna TJ
    Eur J Endocrinol; 2010 Feb; 162(2):213-20. PubMed ID: 19906851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Androgenic alopecia revealing an androgen secreting ovarian tumor].
    Roux-Guinot S; Gorin I; Vadrot D; Djid R; Bethoux JP; Escande JP
    Ann Dermatol Venereol; 2001 Nov; 128(11):1241-4. PubMed ID: 11908171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hirsutism and virilism in women.
    Kirschner MA
    Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone suppression test versus selective ovarian and adrenal vein catheterization in identifying virilizing tumors in postmenopausal hyperandrogenism - a systematic review and meta-analysis.
    Tng EL; Tan JM
    Gynecol Endocrinol; 2021 Jul; 37(7):600-608. PubMed ID: 33660585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approach to the Virilizing Girl at Puberty.
    Santi M; Graf S; Zeino M; Cools M; Van De Vijver K; Trippel M; Aliu N; Flück CE
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1530-1539. PubMed ID: 33367768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Rare Case of Hyperandrogenism Due to Fibrothecoma and Leydig Cell Tumor in a Postmenopausal Woman With Adrenal Adenoma: A Case Report and Literature Review.
    Hussain A; Uy E; Marlowe S; Piercy J; Akbar A
    Cureus; 2023 Aug; 15(8):e43180. PubMed ID: 37692722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary.
    Krug E; Berga SL
    Obstet Gynecol; 2002 May; 99(5 Pt 2):893-7. PubMed ID: 11975949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
    Meczekalski B; Szeliga A; Maciejewska-Jeske M; Podfigurna A; Cornetti P; Bala G; Adashi EY
    Gynecol Endocrinol; 2021 Aug; 37(8):677-682. PubMed ID: 33759685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Case of Ovarian Hyperthecosis in a Postmenopausal Woman.
    Yousaf S; Nizar R; John L; Simpson A
    JCEM Case Rep; 2023 Nov; 1(6):luad148. PubMed ID: 38077307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gonadotropin-Releasing Hormone Analogue Stimulation Test Versus Venous Sampling in Postmenopausal Hyperandrogenism.
    Tng EL; Tan JMM
    J Endocr Soc; 2021 Jan; 5(1):bvaa172. PubMed ID: 33324863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian and adrenal hyperandrogenism.
    Carmina E
    Ann N Y Acad Sci; 2006 Dec; 1092():130-7. PubMed ID: 17308139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of postmenopausal androgen excess.
    Lambrinoudaki I; Dafnios N; Kondi-Pafiti A; Triantafyllou N; Karopoulou E; Papageorgiou A; Augoulea A; Armeni E; Creatsa M; Vlahos N
    Gynecol Endocrinol; 2015 Oct; 31(10):760-4. PubMed ID: 26287476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.